Sustained Release Ocular Bevacizumab
sustained release bevacizumab product
treatment of wet acute macular degeneration
treatment of wet age-related macular degeneration
Prototype SR Bevacizumab products
AMD
processing technology
patient acceptability
economic viability
biodegradable polymers suitable
CriticalMix
safety
advanced manufacturing
Critical Pharmaceuticals
loss of central vision
distortion
cost-effectiveness
drug
blurring
leading cause of blindness
quality of life
feasibility study
eye